Sean A. Mccarthy - Net Worth and Insider Trading
Sean A. Mccarthy Net Worth
The estimated net worth of Sean A. Mccarthy is at least $872,859 dollars as of 2025-05-05. Sean A. Mccarthy is the CEO of CytomX Therapeutics Inc and owns about 1,088,353 shares of CytomX Therapeutics Inc (CTMX) stock worth over $872,859. Details can be seen in Sean A. Mccarthy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean A. Mccarthy has not made any transactions after 2025-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean A. Mccarthy
Sean A. Mccarthy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean A. Mccarthy owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Sean A. Mccarthy’s form 4 insider trades.
Insider Ownership Summary of Sean A. Mccarthy
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2025-03-18 | director & President and CEO |
Sean A. Mccarthy Latest Holdings Summary
Sean A. Mccarthy currently owns a total of 1 stock. Sean A. Mccarthy owns 1,088,353 shares of CytomX Therapeutics Inc (CTMX) as of March 18, 2025, with a value of $872,859.
Latest Holdings of Sean A. Mccarthy
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2025-03-18 | 1,088,353 | 0.80 | 872,859 |
Holding Weightings of Sean A. Mccarthy
Sean A. Mccarthy Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean A. Mccarthy has made a total of 10 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 37,656 shares on March 18, 2025, which brought Sean A. Mccarthy around $22,594.
Insider Trading History of Sean A. Mccarthy
- 1
Sean A. Mccarthy Trading Performance
Sean A. Mccarthy Ownership Network
Ownership Network List of Sean A. Mccarthy
Ownership Network Relation of Sean A. Mccarthy
Sean A. Mccarthy's Executive Compensation Overview
| Company | Year | Salary($) | Bonus($) | Stock Awards($) | Option Awards($) | Equity Awards($) | Non-Equity Incentive Plan($) | All Other Compensation($) | Change in Pension and Deferred Comp($) | Total($) |
|---|---|---|---|---|---|---|---|---|---|---|
| CytomX Therapeutics Inc | 2023 | 652,088 | N/A | 1,048,950 | 533,201 | N/A | 371,899 | 5,000 | N/A | 2,611,138 |
 | | | | | | | | | | |
Sean A. Mccarthy Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Sean A. Mccarthy is the director & President and CEO of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Medical Officer Yu-waye Chu .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Sean A. Mccarthy made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 85,328. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 40,565 shares made by Marcia Belvin , a net sale of 23,729 shares made by Lloyd A Rowland , and a net sale of 15,496 shares made by Christopher Ogden .
In summary, during the past 3 months, insiders sold 79,947 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 79,947 shares. During the past 18 months, 183,963 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,963 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Sean A. Mccarthy Mailing Address
Above is the net worth, insider trading, and ownership report for Sean A. Mccarthy. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sean A. Mccarthy's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
